NRG Therapeutics and Domainex to collaborate on discovery of small molecules to treat Parkinson’s or motor neurone disease

Cambridge Independent

Read more

NRG Therapeutics partners with Domainex to develop neurodegenerative disease...NRG gearing up for series A to advance brain-penetrant PTP inhibitors